引用次数
引用: 10,776
H-指数: 51
I10-指数 : 154
出版物: 361
Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.
Asher A. Chanan-Khan , Kasyapa Chitta , Noreen Ersing , Aneel Paulus
British Journal of Haematology 155 ( 4) 457 -467
56
2011
Central Role of IL-6 Receptor Signal-Transducing Chain gp130 in Activation of L-Selectin Adhesion by Fever-Range Thermal Stress
Qing Chen , Wan-Chao Wang , Robert Bruce , Hong Li
Immunity 20 ( 1) 59 -70
83
2004
Randomized Trial of GM-CSF and G-CSF Following High-Dose Cytarabine and Mitoxantrone Chemotherapy for Relapsed and Refractory Acute Leukemia.
Maria R. Baer , Laurie A. Ford , Brian N. Bundy , Sheila M. Tighe
Blood 108 ( 11) 4574 -4574
1
2006
Proliferation by many other names: Monitoring cell cycle progression and cell division by flow cytometry
Kylie M. Price , Katharine A. Muirhead , Paul K. Wallace
Cytometry Part A 89 ( 3) 233 -235
2
2016
Welcome to Prague CYTO 2018
Andrea Cossarizza , Paul K. Wallace
Cytometry Part A 93 ( 3) 267 -268
1
2018
MiSet RFC Standards: Defining a Universal Minimum Set of Standards Required for Reproducibility and Rigor in Research Flow Cytometry Experiments.
Fabienne Lucas , Jesus Gil‐Pulido , John LaMacchia , Fred Preffer
Cytometry Part A 97 ( 2) 148 -155
2020
Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients.
Jean Grant , Katarzyna Bourcier , Stephen Wallace , Dalin Pan
Cytometry Part B-clinical Cytometry 76 ( 2) 69 -78
30
2009
Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
Minoo Battiwalla , Mehmet Hepgur , Dalin Pan , Philip L. McCarthy
Cytometry Part B-clinical Cytometry 78 ( 5) 348 -356
21
2010
Case study interpretation—Portland: Case 4
Mihai Merzianu , Paul K. Wallace
Cytometry Part B-clinical Cytometry 82 ( 3) 186 -191
6
2012
Issue highlights—July 2014
Paul K. Wallace
Cytometry Part B-clinical Cytometry 86 ( 4) 217 -219
2014
Human B-cell and progenitor stages as determined by probability state modeling of multidimensional cytometry data
C. Bruce Bagwell , Beth L. Hill , Brent L. Wood , Paul K. Wallace
Cytometry Part B-clinical Cytometry 88 ( 4) 214 -226
13
2015
Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma.
Teri A. Oldaker , Paul K. Wallace , David Barnett
Cytometry Part B-clinical Cytometry 90 ( 1) 40 -46
17
2016
Issue highlights – november 2015 (88:B6)
Paul K. Wallace
Cytometry Part B-clinical Cytometry 88 ( 6) 355 -357
2015
Simultaneous measurement of human hematopoietic stem and progenitor cells in blood using multicolor flow cytometry.
Thomas R. Cimato , Rosemary L. Furlage , Alexis Conway , Paul K. Wallace
Cytometry Part B-clinical Cytometry 90 ( 5) 415 -423
14
2016
Interlaboratory comparison of the TransFix®/EDTA Vacuum Blood Collection tube with the 5 mL Cyto‐Chex® BCT
Daniel Harrison , Rosalie Ward , Sarah Bastow , Andrew Parr
Cytometry Part B-clinical Cytometry 96 ( 6) 496 -507
3
2019
CD133 expression in circulating hematopoietic progenitor cells.
Thomas R. Cimato , Alexis Conway , Julianne Nichols , Paul K. Wallace
Cytometry Part B-clinical Cytometry 96 ( 1) 39 -45
1
2019
Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?
Stuart D. Scott , Matthew Fletcher , Helen Whitehouse , Liam Whitby
Cytometry Part B-clinical Cytometry 96 ( 3) 201 -208
5
2019
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing.
D. Robert Sutherland , Andrea Illingworth , Iuri Marinov , Fernando Ortiz
Cytometry Part B-clinical Cytometry 94 ( 1) 23 -48
25
2018
Issue Highlights-May 2018 (94B3).
Paul K. Wallace
Cytometry Part B-clinical Cytometry 94 ( 3) 387 -391
2018
Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease
Kah Teong Soh , Joseph D. Tario , Theresa E Hahn , Jens Hillengass
Cytometry Part B-clinical Cytometry 98 ( 2) 161 -173
7
2020